Superbio AI Announces Initiative with Leading Global Cancer Center to Provide Access to User-Friendly Biomedical AI via the Superbio Marketplace

PALO ALTO, Calif.–(BUSINESS WIRE)–Superbio AI, Inc., announced today that it has entered into an initiative with Memorial Sloan Kettering Cancer Center (MSK) to make user-friendly biomedical AI available for providers, researchers, and drug developers working to advance the standard of care. Under this initative, Superbio AI’s proprietary software platform will be utilized to deploy advanced AI/ML technologies, making them accessible to scientist and physician end-users working on evaluating
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks